Treatment
Delgocitinib clinical trials
We’re tracking 4 recruiting studies that include Delgocitinib, each written for real people, not researchers, below.
Recruiting studies
- NCT07335588RecruitingPhase 3
Testing delgocitinib cream for lichen sclerosus
This trial tests a cream called delgocitinib for adults with lichen sclerosus in the genital area. It aims to see if the cream can safely and effectively reduce symptoms over 52 weeks.
Birmingham, AlabamaAges 18 years+ - NCT07013201RecruitingPhase 2
Testing a new cream for palmoplantar pustulosis
This trial tests a cream called delgocitinib for people with mild to severe palmoplantar pustulosis (PPP), a skin condition with pustules on the palms and soles. The cream is applied daily for 16 weeks to see if it improves symptoms and is safe.
Fountain Valley, CaliforniaAges 18 years+ - NCT07487948RecruitingPhase 2
Testing the drug delgocitinib for two types of scarring hair loss
This study tests an oral medication called delgocitinib, which targets certain enzymes linked to inflammation, in people with central centrifugal cicatricial alopecia (CCCA) or lichen planopilaris (LPP). It aims to see if the drug is safe and if it changes biomarkers (biological signals) related to these conditions.
New York, New YorkAges 18 years+ - NCT07603193Enrolling by invitation
Real-World Study of Delgocitinib Cream for Chronic Hand Eczema
This study tracks how well delgocitinib cream works and how safe it is for people with chronic hand eczema in everyday use. Researchers collect information from your doctor visits to understand if this treatment helps manage your hand eczema symptoms.
Neu-IsenburgAges 18 years+
What Delgocitinib is being studied for
Conditions with recruiting Delgocitinib studies.
Common questions
- Are there clinical trials studying Delgocitinib?
- Yes. Clin2 currently lists 4 recruiting studies that include Delgocitinib, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Delgocitinib trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Delgocitinib an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Delgocitinib or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.